Lovelace Health System completes 1,000 Mako SmartRobotics™ procedures across all applications

CT-based planning allows surgeons to plan and individualize total knee, partial knee and total hip replacement procedures to each patient

ALBUQUERQUE – June 27, 2024 – Lovelace Health System (LHS) has performed a total of 1,059 Mako SmartRobotics™ procedures across all applications – Total Knee, Partial Knee and Total Hip. These procedures were completed at Lovelace Medical Center (LMC), Lovelace Women’s Hospital (LWH) and Lovelace Westside Hospital (LWSH). Mako SmartRobotics™ transforms the way joint replacements are performed, by helping surgeons combine three key components, 3D CT-based planning, AccuStop™ haptic technology and insightful data analytics, into one platform resulting in smaller incisions, less surgery time and better outcomes for patients.

“We are thrilled to have reached this patient milestone and to help our patients get back to activities they love,” said Patrick Gilligan, M.D., Lovelace Medical Group orthopedic surgeon. “With Mako SmartRobotics™, our surgeons can utilize a CT scan, which provides us the ability to create a personalized surgical plan based on each patient’s unique anatomy before entering the operating room.”

Mako Total Knee combines Stryker’s advanced robotic technology with its clinically successful Triathlon Total Knee System, which enables surgeons to have a more predictable surgical experience with increased precision and accuracy.

Mako SmartRobotics™ for Partial Knee replacement is a treatment option designed to relieve the pain caused by joint degeneration due to osteoarthritis that has not yet progressed to all three compartments of the knee. By selectively targeting only the part of the knee damaged by osteoarthritis, surgeons can resurface the diseased portion of the knee while helping to protect the healthy bone surrounding the knee joint. Studies have shown that robotic-arm assisted partial knee replacement has demonstrated increased implant position compared to manual partial knee replacement procedures.

Mako SmartRobotics™ for Total Hip is a treatment option for adults who suffer from degenerative joint disease of the hip. During surgery, the surgeon guides the robotic arm during bone preparation to prepare the hip socket and position the implant according to the predetermined surgical plan. In a controlled matched-paired study to measure acetabular bone resection, results suggested greater bone preservation for Mako Total Hip compared to manual surgery.

“We pride ourselves on providing our patients throughout New Mexico with the highest advanced surgical technology,” said Brian Miller, chief executive officer for LMC. “The Mako SmartRobotics™ at Lovelace help our suregons perform more accurate procedures with faster recovery for our patients, helping us provide the highest quality of care to our community.”

For more information on the Mako SmartRobotics™ surgical system, please visit To learn more about LHS and its commitment to state-of-the-art surgical treatment with quality and compassionate care, please visit


Whitney Alcantar, Lovelace Health System  
Phone: 505.903.0367 

Lovelace Health System
Lovelace is comprised of Lovelace Medical Group/New Mexico Heart Institute, Lovelace Women’s Hospital, Lovelace Medical Center, Heart Hospital of New Mexico at Lovelace Medical Center, Lovelace Westside Hospital, Lovelace Regional Hospital and Lovelace UNM Rehabilitation Hospital. Across its six hospitals, 33 health care clinics and seven outpatient therapy clinics, Lovelace has 619 inpatient beds and employs a team of more than 3,200, including over 300 health care providers. Lovelace continues to invest in our community, providing more than $99 million in unfunded care and supporting local nonprofit and community organizations with more than $315,000 in charitable contributions and community support in 2023. From the first and only hospital in New Mexico dedicated to women’s health to the state’s only hospital devoted exclusively to cardiovascular care, Lovelace is a leader in meeting the healthcare needs of this region. To learn more about our state-of-the-art treatment options, innovative health care providers and award-winning quality initiatives, visit

Lovelace Medical Center
Lovelace Medical Center (LMC), located in the heart of Albuquerque, is a 263-bed acute care hospital with over 1,100 employees providing comprehensive care, including around-the-clock emergency care, surgical services, non-invasive robotic spine surgery, cardiology, stroke care, radiology and oncology services. LMC was recently named to U.S. News & World Report High Performing Best Hospitals, in Heart Attack, Heart Bypass surgery, Heart Failure, Kidney Failure, Stroke and COPD got 2022 -2023 and received the American Heart Association/American Stroke Association Get with the Guidelines Stroke Gold Plus Quality Achievement Award for 2023 for the 11th consecutive year. LMC earned Spine Surgery Program Certification from DNV for 2022- 2025 by demonstrating excellence in orthopedic surgery, including diagnosis and treatments in spine surgery as well as Primary Stroke Center Certification from DNV for 2022 – 2025 for its readiness to handle a full range of stroke-related medical problems. The American Nurses Credentialing Center (ANCC) awarded LMC, one of only 249 programs in the world, the Practice Transitional Accreditation Program (PTAP) for 2023, signifying that the hospital is following best practices and utilizing an evidence-based curriculum that is focused on helping the new graduate nurse transition from student nurse into professional nursing practice. To learn more about the state-of-the-art treatment options, innovative health care providers and award-winning quality initiatives at Lovelace Medical Center, visit